UCSF

ZINC13897226

Substance Information

In ZINC since Heavy atoms Benign functionality
June 28th, 2008 32 Yes

Other Names:

(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid

(R)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid

(S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid

(S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoicacid

(s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid

(s)-3-methyl-2-(pentanoyl-[2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino)-butyric acid 137862-53-

(S)-3-Methyl-2-{pentanoyl-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid

(S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine

(S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine; Diovan; N-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine

sartan

137862-53-4

137862-53-4; D00400; Diovan (TN); Valsartan (JP16/USAN/INN)

3-Methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-butanoic acid

AC-4543

AC1L1U1M

AC1Q5QIK

Ambap137862-53-4

AMLODIPINE; EXFORGE; LS-187829; VALSARTAN

Aventis brand of valsartan

BAN

BIDD:GT0345

Bio-0796

BRD-K45158365-001-02-3

BSPBio_003501

C081489

C24H29N5O3

C24H29N5O3.C7H8ClN3O4S2; DIOVAN HCT; HYDROCHLOROTHIAZIDE; VALSARTAN; LS-178534

CEPA brand of valsartan

CGP 48933

CGP-48933

CHEBI:9927

CHEMBL1069

CID60846

CPD000466318

CPD000466318; SAM001246581; VALSARTAN

CPD000466318; VALSARTAN

D00400

D10226; Sucabitril valsartan sodium hydrate (JAN)

DAP000363

DB00177

Diovan

Diovan (TN)

Diovan, Valsartan

Esteve brand of valsartan

Exforge

FDA

HMS1922L21

HMS2051L12

HMS2093K22

HSDB 7519

INN

Kalpress

KBio2_002287

KBio2_004855

KBio2_007423

KBio3_003006

KBioGR_001078

KBioSS_002289

L-Valine, N-(1-oxopentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-

L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI)

L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-

L-Valsartan

Lacer brand of valsartan

LCZ-696

LCZ-696A

LS-161334

MFCD00865840

MFCD08060556

MFCD18252868

Miten

MLS000759423

MLS001424088

MolPort-002-507-854

MolPort-003-666-608

N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine

N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine

N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine

N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine

N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine

N/A

NA

Nisis

Nisis||

Novartis brand of valsartan

Provas

S1894_Selleck

SAM001246581

Sanol brand of valsartan

Schwarz brand of valsartan

SMR000466318

SPBio_001260

SPECTRUM1505209

Spectrum2_001120

Spectrum3_001831

Spectrum4_000749

Spectrum5_001582

Spectrum_001796

Tareg

TETRAZOLYLBIPHENYLYLMETHYLPENTANAMIDOMETHYLBUTANOICACI

TL8000869

UNII-80M03YXJ7I

USAN)

Vals

Valsarran

Valsartan (BAN

Valsartan (Diovan)

Valsartan (FDA

Valsartan (JAN/USAN/INN)

Valsartan [USAN:INN]

Valtan

walsartan

|Tareg

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 3.08 12.6 -119.08 0 8 -2 113 433.512 10
Lo Low (pH 4.5-6) 3.08 13.62 -64.47 1 8 -1 115 434.52 10

Vendor Notes

Note Type Comments Provided By
MP 117 TCI
ALOGPS_SOLUBILITY 2.34e-02 g/l DrugBank-approved
Purity 95+% Matrix Scientific
Purity 97% Fluorochem
Purity 98% APIChem
mechanism Angiotensin 2 receptor antagonist IBScreen Bioactives
Therapy Angiotensin II inhibitor, antihypertensive SMDC Iconix
Indications antihypertensive KeyOrganics Bioactives
biological_use Antihypertensive agent IBScreen Bioactives
Patent Database Links EP1106210; EP1197226; EP1329218; EP1356815; EP1514543; EP1533305; EP1553091; EP1559424; EP1579862; EP1579872; EP1588706; EP1611886; EP1627638; EP1629835; EP1661891; EP1671632; EP1674080; EP1714651; EP1714963; EP1723962; EP1746099; EP1774967; EP1776953; EP ChEBI
Warnings IRRITANT Matrix Scientific
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP00900v NIH Clinical Collection via PubChem
Target RAAS Selleck Chemicals
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP00900v NIH Clinical Collection via PubChem

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
AGTR1-1-E Type-1 Angiotensin II Receptor (cluster #1 Of 2), Eukaryotic Eukaryotes 4700 0.23 Binding ≤ 10μM
AGTRA-1-E Angiotensin II Type 1a (AT-1a) Receptor (cluster #1 Of 1), Eukaryotic Eukaryotes 3 0.37 Binding ≤ 10μM
AGTRB-1-E Angiotensin II Type 1b (AT-1b) Receptor (cluster #1 Of 1), Eukaryotic Eukaryotes 3 0.37 Binding ≤ 10μM
Z50592-3-O Oryctolagus Cuniculus (cluster #3 Of 8), Other Other 1 0.39 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
AGTR1_HUMAN P30556 Angiotensin II Type 1 Receptor, Human 2.7 0.37 Binding ≤ 1μM
AGTRA_RAT P25095 Angiotensin II Type 1a (AT-1a) Receptor, Rat 2.7 0.37 Binding ≤ 1μM
AGTRB_RAT P29089 Angiotensin II Type 1b (AT-1b) Receptor, Rat 1.9 0.38 Binding ≤ 1μM
AGTR1_HUMAN P30556 Angiotensin II Type 1 Receptor, Human 2.7 0.37 Binding ≤ 10μM
AGTRA_RAT P25095 Angiotensin II Type 1a (AT-1a) Receptor, Rat 2.7 0.37 Binding ≤ 10μM
AGTRB_RAT P29089 Angiotensin II Type 1b (AT-1b) Receptor, Rat 1.9 0.38 Binding ≤ 10μM
Z50592 Z50592 Oryctolagus Cuniculus 1.4 0.39 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
G alpha (q) signalling events
Peptide ligand-binding receptors

Analogs ( Draw Identity 99% 90% 80% 70% )